openPR Logo
Press release

Reye’s Syndrome Market 2018 Rise With CAGR of 7.20% Till 2023 | Siemens Healthcare, NeuroLogica, AstraZeneca, General Electric Company, Pfizer And More

05-09-2018 03:42 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Reye?s Syndrome Market

Reye?s Syndrome Market

Market Research Future published a research report on Global Reye’s Syndrome Market and predicts that Global Reye’s Syndrome Market is expected to grow at a healthy CAGR of 7.20% during the forecasted period and report include market Analysis, Scope, Stake, Progress, Trends and forecast till 2023.

Reye’s syndrome is a rare disease that causes swelling of the liver and brain. Increasing prevalence of influenza and rising teenage population are the major drivers of the market growth. Moreover, increasing per capita healthcare expenditure and developing biotechnology & pharmaceutical industries within the developing economies across the world are estimated to boost the market growth during the forecasted period. However, lack of awareness, limited treatment options, and FDA approvals may restrain the market growth during the forecast period.

Increasing prevalence of influenza and teenage population are the major drivers of the market growth. According to the 2015-2016 Influenza Burden Estimates of the Centers for Disease Control and Prevention, 9.2-35.6 million cases of influenza led to 140,000-710,000 hospitalizations and caused 12,000- 56,000 deaths annually since 2010. according to the Child Trends, the number of children under 18 years of age is projected to increase from 74.1 million to 78.2 million by 2040

The Global market for Reye's Syndrome is estimated to grow at an approximate CAGR of 7.20% from 2017 to 2023.

Get PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5302 .

Key Players for Global Reye’s Syndrome Market

General Electric Company (U.S.), Siemens Healthcare GmbH (Germany), CANON MEDICAL SYSTEMS CORPORATION (Japan), Koninklijke Philips N.V. (The Netherlands), NeuroLogica Corp. (U.S.), Sumitomo Corporation (Japan), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K), Eli Lilly and Company (U.S.), Biocon (India), Ypsomed (Switzerland), BD (U.S.), ARGON MEDICAL (U.S.), and others.

Segments for Global Reye’s Syndrome Market

The Global Reye’s Syndrome Market is segmented on the basis of diagnosis, treatment and end users.

On the basis of the diagnosis, the market is segmented into tests, biopsy, imaging, and others. The test segment is sub-segmented into blood tests, urine tests, and others. The biopsy segment is sub-segmented into liver biopsy, skin biopsy, and others. The imaging segment is sub-segmented into computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and others.

On the basis of the treatment, the market is categorized into electrolytes and fluids, corticosteroids, ammonia detoxicants, insulin, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, research laboratories, diagnostic centers, and others.

Regional Analysis for Global Reye’s Syndrome Market

The Americas hold the major share of the Global Reye’s Syndrome Market. The presence of a well-developed healthcare sector, rising healthcare expenditures, and growing adolescent population are the major drivers of the market growth within the region.

Europe holds the second largest market for Reye’s syndrome. Availability of funds for research and government support for research & development are the major drives for the growth of the market within the region.

Asia Pacific is the fastest growing region for the market due to the presence of continuously developing economies. Moreover, growing the pharmaceutical sector and expanding healthcare sector is estimated to drive the market growth within the region.

On the other hand, the Middle East & Africa has the least share of the Global Reye’s Syndrome Market. Presence of poor economies and stringent government policies, especially within the African region, are restraining the market growth within the region. A majority of the market of this region is held by the Middle East.

Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/5302 .

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

For Enquiry Related Report Click @ https://www.marketresearchfuture.com/enquiry/5302 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Reye’s Syndrome Market 2018 Rise With CAGR of 7.20% Till 2023 | Siemens Healthcare, NeuroLogica, AstraZeneca, General Electric Company, Pfizer And More here

News-ID: 1044921 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Reye

Colonoscopes Market Will Reach at USD 3.23 billion by 2030
DBMR team of skilled analysts, statisticians, research experts, enthusiastic forecasters, and economists work painstakingly to structure such a great market report for the businesses seeking a potential growth. This team is focused on understanding client's businesses and its needs so that the finest market research report is delivered to the client. With the use of up to date and proven tools and techniques, complex market insights are organized in simpler
Hand, Foot and Mouth Disease Treatment Market Growth Factors, Opportunities, Ong …
Based on drug type, Acetaminophen registers the highest demand in the hand, foot and mouth disease treatment market owing to the less side effects registered with usage of this drug as compared to others. Hand, foot and mouth disease treatment found major usage in management of blisters in mouth and rashes on hands and feet. Rising prevalence of viral infections in children below age 10 and growing economic burden caused by
Conversational AI To Be The Driver For External Ventricular Drain Market
The evolution of external ventricular drains can be distributed over four eras: the development of the technique (1850 - 1950), technological innovation and advancements (1927 - 1950), expansion of the indications (1960 - 1995), and accuracy, infection control, and training (1995 - present). Various neurosurgical procedures have been enhanced with the incorporation of computer-assisted navigation using a combination of patient anatomy and imaging in external ventricular drains. This technology has been incorporated
Reye Syndrome Market 2021 | Growth By Top Companies, Regions, Types, Application …
Reye syndrome treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.80% in the above-mentioned research forecast period. Increasing population of children worldwide and growing cases of influenza infections among children. Advancement in diagnostic tools so as to accurately diagnose the disease symptoms and developing biotechnology and pharmaceutical sector also boost
External Ventricular Drain Market Is Expected To Reach $5.1 Billion by 2031, Gro …
According to a new market research report published by sheer analytics and insights, “The Global External Ventricular Drain Market was valued at $5.1 Billion in 2020. Growing at a high CAGR of more than 7.3% between 2021 and 2031, it is estimated to reach $11.3 Billion by 2031”, as per the latest market research report titled, Global External Ventricular Drain Market - industry analysis, size, share, growth, trends and forecast,
Reye ’s syndrome Market 2019 Competitive Players as  General Electric Company …
Global Reye ’s syndrome Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa. And It Is Incorporated On Marketresearchfuture.Com With 90 Pages. Reye ’s syndrome Market Is relied upon to develop a 7.20% CAGR during The Forecast Period 2018 To 2023. Reye ’s syndrome Market – Synopsis Global Reye's syndrome Market is estimated to grow